Selleck Chemicals - Model A2343 -Vandortuzumab (Anti-STEAP1)

Vandortuzumab (Anti-STEAP1) is a recombinant monoclonal antibody that specifically targets STEAP1. It has potential for the treatment of prostate cancer. MW : 145.5 KD.